LITTLE KNOWN FACTS ABOUT CONOLIDINE.

These success, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two aid the strategy of targeting ACKR3 as a singular solution to modulate the opioid technique, which could open new therapeutic avenues for opioid-similar disorders.A study examine printed in Anesthesiology